The autoimmune disease-associated IL2RA locus is involved in the clinical manifestations of systemic sclerosis

被引:18
|
作者
Martin, J-E [1 ]
Carmona, F. D. [1 ]
Broen, J. C. A. [2 ]
Simeon, C. P. [3 ]
Vonk, M. C. [2 ]
Carreira, P. [4 ]
Rios-Fernandez, R. [5 ]
Espinosa, G. [6 ]
Vicente-Rabaneda, E. [7 ]
Tolosa, C. [8 ]
Garcia-Hernandez, F. J. [9 ]
Castellvi, I. [10 ]
Fonollosa, V. [3 ]
Gonzalez-Gay, M. A. [11 ]
Saez-Comet, L. [12 ]
Garcia Portales, R. [13 ]
Garcia de la Pena, P. [14 ]
Fernandez-Castro, M. [15 ]
Diaz, B. [16 ]
Martinez-Estupinan, L. [17 ]
Coenen, M. [18 ]
Voskuyl, A. E. [19 ]
Schuerwegh, A. J. [20 ]
Vanthuyne, M. [21 ]
Houssiau, F. [21 ]
Smith, V. [22 ]
de Keyser, F. [22 ]
De Langhe, E. [23 ]
Riemekasten, G. [24 ]
Witte, T. [25 ]
Hunzelmann, N. [26 ]
Kreuter, A. [27 ]
Palm, O. [28 ]
Chee, M. M. [29 ]
van Laar, J. M. [30 ]
Denton, C. [31 ]
Herrick, A. [32 ]
Worthington, J. [32 ]
Koeleman, B. P. C. [33 ]
Radstake, T. R. D. J. [2 ]
Fonseca, C. [31 ]
Martin, J. [1 ]
机构
[1] CSIC, Inst Parasitol & Biomed Lopez Neyra, Granada 18100, Spain
[2] Radboud Univ Nijmegen, Med Ctr, Dept Rheumatol, NL-6525 ED Nijmegen, Netherlands
[3] Hosp Valle de Hebron, Dept Internal Med, Barcelona, Spain
[4] Hosp 12 Octubre, Dept Rheumatol, E-28041 Madrid, Spain
[5] Hosp Clin San Cecilio, Dept Internal Med, Granada, Spain
[6] Hosp Clin Barcelona, Dept Autoimmune Dis, Barcelona, Spain
[7] Hosp Princesa, Dept Rheumatol, Madrid, Spain
[8] Hosp Parc Tauli, Dept Internal Med, Sabadell, Spain
[9] Hosp Virgen del Rocio, Dept Internal Med, Seville, Spain
[10] Hosp Santa Creu & Sant Pau, Dept Rheumatol, Barcelona, Spain
[11] Hosp Univ Marques de Valdecilla, IFIMAV, Dept Rheumatol, Santander, Spain
[12] Hosp Univ Miguel Servet, Dept Internal Med, Zaragoza, Spain
[13] Hosp Virgen de la Victoria, Dept Rheumatol, Malaga, Spain
[14] Hosp Univ Madrid Norte Sanchinarro, Dept Rheumatol, Madrid, Spain
[15] Hosp Puerta de Hierro, Dept Rheumatol, Madrid, Spain
[16] Hosp Cent Asturias, Dept Internal Med, Oviedo, Spain
[17] Hosp Gen Univ Gregorio Maranon, Dept Rheumatol, Madrid, Spain
[18] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6525 ED Nijmegen, Netherlands
[19] Vrije Univ Amsterdam Med Ctr, Dept Rheumatol, Amsterdam, Netherlands
[20] Leiden Univ, Med Ctr, Dept Rheumatol, Leiden, Netherlands
[21] Catholic Univ Louvain, Clin Univ St Luc, B-1200 Brussels, Belgium
[22] Univ Ghent, Dept Rheumatol, B-9000 Ghent, Belgium
[23] Univ Louvain, KULeuven, Louvain, Belgium
[24] Charite, Dept Rheumatol & Clin Immunol, Berlin, Germany
[25] Hannover Med Sch, D-3000 Hannover, Germany
[26] Univ Cologne, Dept Dermatol, Cologne, Germany
[27] Ruhr Univ Bochum, Dept Dermatol, Bochum, Germany
[28] Oslo Univ Hosp, Rikshosp, Dept Rheumatol, Oslo, Norway
[29] Glasgow Royal Infirm, Ctr Rheumat Dis, Glasgow G4 0SF, Lanark, Scotland
[30] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England
[31] Royal Free & Univ Coll Med Sch, Ctr Rheumatol, London WC1E 6BT, England
[32] Univ Manchester, Manchester Acad Hlth Sci Ctr, Arthrit Res UK Epidemiol Unit, Manchester, Lancs, England
[33] Univ Med Ctr Utrecht, Dept Med Genet, Utrecht, Netherlands
关键词
systemic sclerosis; anti-centromere auto-antibody; IL2RA; rs11594656; rs2104286; rs12722495; REGULATORY T-CELLS; INTERLEUKIN-2-RECEPTOR; CLASSIFICATION; PATHOGENESIS;
D O I
10.1038/gene.2011.72
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Regulatory T cells (T-regs) are crucial in the maintenance of the immune tolerance and seem to have an important role in systemic sclerosis (SSc). The interleukin 2 receptor alpha (IL2RA) is an important T-reg marker, and polymorphisms of IL2RA gene are associated with a number of autoimmune diseases. Therefore, we aimed to investigate for the first time the association of the IL2RA locus in SSc. For this purpose, a total of 3023 SSc patients and 2735 matched healthy controls, from six European Caucasian cohorts, were genotyped for the IL2RA gene variants rs11594656, rs2104286 and rs12722495 using the TaqMan allelic discrimination technology. The overall meta-analysis reached statistical significance when the three polymorphisms were tested for association with SSc, the limited subtype (lcSSc) and anti-centromere auto-antibodies (ACAs). However, no significant P-values were obtained when the ACA-positive patients were removed from the SSc and lcSSc groups, suggesting that these associations rely on ACA positivity. The strongest association signal with ACA production was detected for rs2104286 (P-FDR 2.07 x 10(-4,) odds ratio = 1.30 (1.14-1.47)). The associations of rs11594656 and rs12722495 were lost after conditioning to rs2104286, and allelic combination tests did not evidence a combined effect, indicating that rs2104286 best described the association between IL2RA and ACA presence in SSc. Genes and Immunity (2012) 13, 191-196; doi:10.1038/gene.2011.72; published online 20 October 2011
引用
收藏
页码:191 / 196
页数:6
相关论文
共 50 条
  • [41] Current concepts in disease-modifying therapy for systemic sclerosis-associated interstitial lung disease: Lessons from clinical trials
    Tashkin D.P.
    Au K.
    Khanna D.
    Clements P.J.
    Furst D.E.
    Current Rheumatology Reports, 2009, 11 (2) : 111 - 119
  • [42] Heterogeneity of determining disease severity, clinical course and outcomes in systemic sclerosis-associated interstitial lung disease: a systematic literature review
    Petelytska, Liubov
    Bonomi, Francesco
    Cannistra, Carlo
    Fiorentini, Elisa
    Peretti, Silvia
    Torracchi, Sara
    Bernardini, Pamela
    Coccia, Carmela
    De Luca, Riccardo
    Economou, Alessio
    Levani, Juela
    Matucci-Cerinic, Marco
    Distler, Oliver
    Bruni, Cosimo
    RMD OPEN, 2023, 9 (04):
  • [43] Increased Plasma Soluble Interleukin-2 Receptor Alpha Levels in Patients With Long-Term Type 1 Diabetes With Vascular Complications Associated With IL2RA and PTPN2 Gene Polymorphisms
    Keindl, Magdalena
    Fedotkina, Olena
    du Plessis, Elsa
    Jain, Ruchi
    Bergum, Brith
    Mygind Jensen, Troels
    Laustrup Moller, Cathrine
    Falhammar, Henrik
    Nystrom, Thomas
    Catrina, Sergiu-Bogdan
    Jorneskog, Gun
    Groop, Leif
    Eliasson, Mats
    Eliasson, Bjorn
    Brismar, Kerstin
    Nilsson, Peter M.
    Berg, Tore Julsrud
    Appel, Silke
    Lyssenko, Valeriya
    FRONTIERS IN ENDOCRINOLOGY, 2020, 11
  • [44] Clinical Relevance of the Serial Measurement of Krebs von den Lungen-6 Levels in Patients with Systemic Sclerosis-Associated Interstitial Lung Disease
    Shirai, Yuichiro
    Fukue, Ryosuke
    Kaneko, Yuko
    Kuwana, Masataka
    DIAGNOSTICS, 2021, 11 (11)
  • [45] Improvement in the clinical manifestations of interstitial lung disease following treatment with placental mesenchymal stromal cell extracellular vesicles in a patient with systemic sclerosis: A case report
    Assar, Shirin
    Mohammadzadeh, Dena
    Norooznezhad, Amir Hossein
    Payandeh, Mehrdad
    Hassaninia, Daryoush
    Pournazari, Mehran
    Soufivand, Parviz
    Yarani, Reza
    Mansouri, Kamran
    RESPIRATORY MEDICINE CASE REPORTS, 2023, 46
  • [46] ANTI-RO/SSA - POSITIVE SYSTEMIC SCLEROSIS - COMMONLY ASSOCIATED CLINICAL AND SEROLOGICAL FEATURES INDEPENDENTLY FROM THE UNDERLYING DISEASE
    Groseanu, L.
    Cristina, N.
    Nicoara, D.
    Belinski, D. Opris
    Predeteanu, D.
    Bojinca, V.
    Berghea, F.
    Saulescu, I.
    Daia-Iliescu, S.
    Mazilu, D.
    Borangiu, A.
    Negru, M. M.
    Cobilinschi, C.
    Mardale, D.
    Constantinescu, C. L.
    Duna, M.
    Vlad, V.
    Abobului, M.
    Ionescu, R.
    Balanescu, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1010 - 1010
  • [47] Systemic Sclerosis-Associated Interstitial Lung Disease: Lessons from Clinical Trials, Outcome Measures, and Future Study Design
    Khanna, Dinesh
    Seibold, James R.
    Wells, Athol
    Distler, Oliver
    Allanore, Yannick
    Denton, Chris
    Furst, Daniel E.
    CURRENT RHEUMATOLOGY REVIEWS, 2010, 6 (02) : 138 - 144
  • [48] Clinical Predictors of Lung-Function Decline in Systemic-Sclerosis-Associated Interstitial Lung Disease Patients with Normal Spirometry
    Nagy, Tamas
    Toth, Nora Melinda
    Palmer, Erik
    Polivka, Lorinc
    Csoma, Balazs
    Nagy, Alexandra
    Eszes, Noemi
    Vincze, Krisztina
    Barczi, Eniko
    Bohacs, Aniko
    Tarnoki, Adam Domonkos
    Tarnoki, David Laszlo
    Nagy, Gyorgy
    Kiss, Emese
    Maurovich-Horvat, Pal
    Muller, Veronika
    BIOMEDICINES, 2022, 10 (09)
  • [49] Anti-RNA Polymerase III Antibody Prevalence and Associated Clinical Manifestations in a Large Series of French Patients with Systemic Sclerosis: A Cross-sectional Study
    Meyer, Olivier
    De Chaisemartin, Luc
    Nicaise-Roland, Pascale
    Cabane, Jean
    Tubach, Florence
    Dieude, Philippe
    Hayem, Gilles
    Palazzo, Elisabeth
    Chollet-Martin, Sylvie
    Kahan, Andre
    Allanore, Yannick
    JOURNAL OF RHEUMATOLOGY, 2010, 37 (01) : 125 - 130
  • [50] Interferon III-related IL28RA variant is associated with rheumatoid arthritis and systemic lupus erythematosus and specific disease sub-phenotypes
    Drehmer, Manuela Nunes
    Castro, Gabriel Vaisam
    Pereira, Ivanio Alves
    de Souza, Iliada Rainha
    Lofgren, Sara Emelie
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2021, 24 (01) : 49 - 55